内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2020 TES临床实践指南：内分泌疾病患者的血脂管理

2020-12-01 美国内分泌学会 J Clin Endocrinol Metab. 2020 Dec 1;105(12):1-70.

内分泌疾病血脂管理

2020年12月，美国内分泌学会(TES)发布了内分泌疾病患者的血脂管理指南，本文主要针对内分泌疾病患者血脂异常的诊断和管理提供指导建议，目的是预防心血管事件和甘油三酯诱导的胰腺炎。

中文标题：

2020 TES临床实践指南：内分泌疾病患者的血脂管理

英文标题：

Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline

发布机构：

美国内分泌学会

发布日期：

2020-12-01

简要介绍：

2020年12月，美国内分泌学会(TES)发布了内分泌疾病患者的血脂管理指南，本文主要针对内分泌疾病患者血脂异常的诊断和管理提供指导建议，目的是预防心血管事件和甘油三酯诱导的胰腺炎。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 TES临床实践指南：内分泌疾病患者的血脂管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7d7b31c002029568, title=2020 TES临床实践指南：内分泌疾病患者的血脂管理, enTitle=Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, guiderFrom=J Clin Endocrinol Metab. 2020 Dec 1;105(12):1-70., authorId=0, author=, summary=2020年12月，美国内分泌学会(TES)发布了内分泌疾病患者的血脂管理指南，本文主要针对内分泌疾病患者血脂异常的诊断和管理提供指导建议，目的是预防心血管事件和甘油三酯诱导的胰腺炎。, cover=https://img.medsci.cn/20201224/1608742707530_2020535.jpg, journalId=0, articlesId=null, associationId=129, associationName=美国内分泌学会, associationIntro=美国内分泌学会（The Endocrine Society）成立于1916年，是激素研究和内分泌学临床实践世界最大、最古老，也是最活跃的机构，致力于提升公众和其他医务人员对于内分泌学的了解，提高内分泌学者在国家科研和医疗政策层面的影响。学会现拥有来自100多个国家的约14000名会员，遍布医学、分子生物学、细胞生物学、生物化学、生理学、基因学、免疫学、教育等相关领域，包括临床医生、研究员、教师、学生、内分泌学领域的相关专业人员。学会出版专业期刊和杂志，举办国际会议，为医师提供教育培训项目，发布临床实践指南，积极募集相关研究资助，推动相关政策发展。, copyright=0, guiderPublishedTime=Tue Dec 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月，美国内分泌学会(TES)发布了内分泌疾病患者的血脂管理指南，本文主要针对内分泌疾病患者血脂异常的诊断和管理提供指导建议，目的是预防心血管事件和甘油三酯诱导的胰腺炎。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=10098, tagName=内分泌疾病), TagDto(tagId=11177, tagName=血脂管理)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10098, guiderKeyword=内分泌疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13089, appHits=321, showAppHits=0, pcHits=778, showPcHits=12768, likes=2, shares=39, comments=30, approvalStatus=1, publishedTime=Thu Dec 24 00:58:41 CST 2020, publishedTimeString=2020-12-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Dec 24 00:58:33 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 02:45:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 TES临床实践指南：内分泌疾病患者的血脂管理.pdf)])
2020 TES临床实践指南：内分泌疾病患者的血脂管理.pdf
下载请点击：
评论区 (22)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1068868, encodeId=87b21068868fb, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Wed Nov 10 07:33:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067585, encodeId=d0a7106e585ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=081f5687511, createdName=ms9000000892709945, createdTime=Sat Nov 06 14:40:56 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975881, encodeId=54309e58819f, content=有没有解读呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:35 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975880, encodeId=2b809e588002, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:29 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969404, encodeId=d89b969404eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/25ad613a8c0141f3a9f43287cb7c6b76/75f16d1f44624944b17a6579019650cb.jpg, createdBy=d6705509111, createdName=扫地小僧, createdTime=Sat May 29 11:40:57 CST 2021, time=2021-05-29, status=1, ipAttribution=)]
    2021-11-10 策瑜爱发呆

    认真学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1068868, encodeId=87b21068868fb, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Wed Nov 10 07:33:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067585, encodeId=d0a7106e585ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=081f5687511, createdName=ms9000000892709945, createdTime=Sat Nov 06 14:40:56 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975881, encodeId=54309e58819f, content=有没有解读呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:35 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975880, encodeId=2b809e588002, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:29 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969404, encodeId=d89b969404eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/25ad613a8c0141f3a9f43287cb7c6b76/75f16d1f44624944b17a6579019650cb.jpg, createdBy=d6705509111, createdName=扫地小僧, createdTime=Sat May 29 11:40:57 CST 2021, time=2021-05-29, status=1, ipAttribution=)]
    2021-11-06 ms9000000892709945

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1068868, encodeId=87b21068868fb, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Wed Nov 10 07:33:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067585, encodeId=d0a7106e585ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=081f5687511, createdName=ms9000000892709945, createdTime=Sat Nov 06 14:40:56 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975881, encodeId=54309e58819f, content=有没有解读呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:35 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975880, encodeId=2b809e588002, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:29 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969404, encodeId=d89b969404eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/25ad613a8c0141f3a9f43287cb7c6b76/75f16d1f44624944b17a6579019650cb.jpg, createdBy=d6705509111, createdName=扫地小僧, createdTime=Sat May 29 11:40:57 CST 2021, time=2021-05-29, status=1, ipAttribution=)]
    2021-06-22 ms7000001881586700

    有没有解读呀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1068868, encodeId=87b21068868fb, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Wed Nov 10 07:33:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067585, encodeId=d0a7106e585ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=081f5687511, createdName=ms9000000892709945, createdTime=Sat Nov 06 14:40:56 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975881, encodeId=54309e58819f, content=有没有解读呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:35 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975880, encodeId=2b809e588002, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:29 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969404, encodeId=d89b969404eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/25ad613a8c0141f3a9f43287cb7c6b76/75f16d1f44624944b17a6579019650cb.jpg, createdBy=d6705509111, createdName=扫地小僧, createdTime=Sat May 29 11:40:57 CST 2021, time=2021-05-29, status=1, ipAttribution=)]
    2021-06-22 ms7000001881586700

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1068868, encodeId=87b21068868fb, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Wed Nov 10 07:33:21 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067585, encodeId=d0a7106e585ee, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=081f5687511, createdName=ms9000000892709945, createdTime=Sat Nov 06 14:40:56 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975881, encodeId=54309e58819f, content=有没有解读呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:35 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975880, encodeId=2b809e588002, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fefe5459581, createdName=ms7000001881586700, createdTime=Tue Jun 22 18:38:29 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969404, encodeId=d89b969404eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/25ad613a8c0141f3a9f43287cb7c6b76/75f16d1f44624944b17a6579019650cb.jpg, createdBy=d6705509111, createdName=扫地小僧, createdTime=Sat May 29 11:40:57 CST 2021, time=2021-05-29, status=1, ipAttribution=)]
    2021-05-29 扫地小僧

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 ESE声明：COVID-19和内分泌疾病

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-04-11

2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2018-03-16

拓展阅读

2018 EHRA意见书：内分泌疾病患者的心律失常管理和设备治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2018-03-16

2020 ESE声明：COVID-19和内分泌疾病

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-04-11

2022 KES立场声明：免疫检查点抑制剂和内分泌疾病

韩国内分泌学会(KES,Korean Endocrine Society) · 2022-12-23

生酮饮食与慢性疾病的研究进展

暂未更新 · 2022-09-30